In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
COVID-19 will spur decentralised and hybrid trials – Novartis hails digital investment
An article featuring commentary from Dr. Nuala Murphy regarding the use of decentralised and hybrid trials during the COVID-19 crisis.
-
Transforming cell and gene therapy trial design and execution
With over 400 dedicated Cell and Gene Therapy professionals globally, ICON has developed tools and best practices to transform CGT trial design and execution.
-
COVID-19 vaccine response
James Cummings, President, ICON Government & Public Health Solutions, and Beth Tulip, Vice President, Project Management, Vaccines & Infectious Diseases, discuss developments in vaccine research efforts and key challenges of delivering a coronavirus vaccine.
-
Five common literature reviews for RWE generation
Systematic literature reviews are considered the gold standard for reporting in evidence-based healthcare, but not all literature reviews are created equally. In this Pharmafocus article, ICON's Alexia Burton, Ram Mishra and Rob Sambrook discuss how having a clear understanding of the purpose, audience, timing and available resources can guide researchers to the most effective approach.
-
Translation services and the race for a coronavirus vaccine
An article featuring commentary from Adelina Lear regarding the role of language services in the drug development lifecycle.
-
ICON launches Coronavirus Observatory
This article discusses ICON’s Coronavirus Observatory, a tool providing real-time updates on COVID-19 vaccine trials, and insights into key issues.
Read more about ICON's expertise in COVID-19 clinical trials.
-
Role of data in revolutionising the CRO industry
In a wide-ranging interview with PharmaBoardroom, ICON CIO, Tom O’Leary highlights the role of data in revolutionising the CRO industry and the steps that still need to be taken to better match patients with targeted therapies and improve health outcomes.
-
Fast vs. Formulated
An article published by PharmTech.com which features expert commentary from ICON's VP of Drug Development and Consulting, Stuart Madden.
-
Seeking early answers to formulation questions
ICON's Stuart Madden provides expert commentary on drug development in this March 2020 BioPharm International article.
-
Mapping the patient journey and minding the gap
An article featuring commentary by Gretchen Goller which highlights seven steps to closing the gap between rhetoric and reality in patient-centricity.
